Clinical Trial Update: Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of an antioxidant therapy in chronic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ATIC antioxidant therapy

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Chronic Kidney Disease | Phase 4 | Status: TERMINATED